Cook Meredith 4
4 · ANI PHARMACEUTICALS INC · Filed Feb 18, 2025
Insider Transaction Report
Form 4
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Transactions
- Award
Common Stock
2025-02-12+11,316→ 83,878 total - Award
Common Stock
2025-02-12+16,974→ 72,562 total - Sale
Common Stock
2025-02-13$59.54/sh−400$23,816→ 83,478 total - Tax Payment
Common Stock
2025-02-14$58.92/sh−1,434$84,491→ 82,044 total
Footnotes (4)
- [F1]Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025.
- [F2]These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.
- [F3]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024.
- [F4]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,690 shares of restricted stock, the grant of which was previously reported.